For media inquiries and interview requests
For comments on issues of local or provincial interests:
Nina Snyder Chief Operations Officer Phone: 780-488-6819 (Extension 2232) Email: nsnyder@ablung.ca
Latest News
Sept 2021
Provincial guidance on the Philips NIV/Ventilator RECALL
May 2021
January 2021
PRIORITIZATION OF CANADIANS WITH LUNG DISEASE IN COVID-19 VACCINATION ROLLOUT - A Joint Statement
November 2020
A Patient Charter for Chronic Obstructive Pulmonary Disease (COPD)
March 2020
16/03/2020 COVID-19 Frequently Asked Questions
06/03/2020 COVID-19 places scrutiny on handwashing. Tips for better handwashing!
06/03/2020 Statistics Canada released the results of a 2019 vaping survey. The results reinforced what we have known for a while now – that there is a vaping crisis among Canadian youth. See the complete results.
Jan 2020
31/01/2020 World Health Organization declares public health emergency over global outbreak of Coronavirus
06/01/2020 
Press Release - Radon Screening Kits Available at Parkland Regional Library
02/01/2020 Media Release - Case of severe vaping illness reported in Alberta
November 2019
07/11/2019 Edmonton grown device breathes new life into lung transplant Edmonton Sun Read how Alberta Lung plans to help patients
07/11/2019 Article - Radon Screening Kits Available at Red Deer Public Library
04/11/2019 NEWS RELEASE: Albertans want provincial vaping restrictions aligned with tobacco restrictions
04/11/2019 Media Release - Radon Screening Kits Available at EPL
October 2019
31/10/2019 Press Release - Radon Screening Kits Available at Red Deer Public Library
September 2019
19/09/2019 Vaping: The time to act is now.
June 2019
After decades of decline; tobacco is once again butting into young lives!
January 2019
Edmonton, Alberta– 24 January 2019 – Moving the Dial on the Diagnosis and Treatment of Asthma
October 2018
Alberta Lung offering 100 citizens an incentive to quit smoking cold turkey on Nov 1 The Medicine Hat News
September 2018
Groundbreaking research funded by donors of Alberta Lung & NWT on Asthma!
September 2018
Alberta Lung & NWT has joined the Aeroplan Member Donation Program
November 2017
Watch our interview on Alberta Primetime introducing Breathing Space!
July 2017
April 2017
January 2017
Alberta Drug Benefits Updates
The complete list of Alberta drug benefits, changes and criteria for coverage can be found by clicking Alberta Drug Benefit List (ADBL)
Changes to the Alberta Drug Plan coverage of certain medications for Idiopathic Pulmonary Fibrosis available by Special Authorization (ABC 60051):
- nintedanib, capsule, 100mg, 150mg; brand name OFEV
Used for the treatment of Idiopathic Pulmonary Fibrosis - pirfenidone, capsule, 267mg; brand name Esbriet
Used for the treatment of Idiopathic Pulmonary Fibrosis - Download Alberta Blue Cross Nintedanib/Pirfenidone Special Authorization Request Form (ABC 60051)